Rotavirus vaccine 116E (Bharat Biotech)

轮状病毒疫苗116E

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRotavirus vaccine 116E (Bharat Biotech)
Drug Alias NameOral Rotavirus Vaccine 116E Live AttenuatedROTAVAC 5CMVero cell-based 116E neonatal rotavirus vaccineRotavac116-E +[6] 
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDiarrheaGastroenteritisRotavirus Infections
Global Approved IndicationsRotavirus Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2013/09/01
Country/TerritoryZambiaVietnamChile +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBharat Biotech International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBharat Biotech International LtdUniversity Of Chile
Inactive CompaniesInstitute Of Clinical Research And Clinical Trial Support For Vaccine And Biological Products
Active IndicationsGastroenteritisRotavirus Infections
Inactive IndicationsDiarrhea

Other Information

ATC CodeJ07BH
Related LinksDrugBank